INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Optimal sizing for SAPIEN 3 transcatheter aortic valve replacement in patients with or without left ventricular outflow tract calcification

EuroIntervention 2017;12:e2177-e2185 published online January 2017 published online e-edition April 2017. DOI: 10.4244/EIJ-D-16-00806

Yoshio Maeno, MD, PhD; Yigal Abramowitz, MD; Hasan Jilaihawi, MD; Sharjeel Israr, MD; Sunghan Yoon, MD; Rahul P. Sharma, MD; Yoshio Kazuno, MD; Hiroyuki Kawamori, MD, PhD; Masaki Miyasaka, MD; Tanya Rami, MBA; Geeteshwar Mangat, MD; Nobuyuki Takahashi, MD; Kazuaki Okuyama, MD; Mohammad Kashif, MD; Tarun Chakravarty, MD; Mamoo Nakamura, MD; Wen Cheng, MD; Raj R. Makkar*, MD

Cedars-Sinai Medical Center, Heart Institute, Los Angeles, CA, USA

Aims: The impact of left ventricular outflow tract calcification (LVOT-CA) on SAPIEN 3 transcatheter aortic valve replacement (S3-TAVR) is not well understood. The aims of the present stu

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

annulus ruptureaortic stenosismultislice computed tomography (msct)paravalvular leaktranscatheter aortic valve replacement (tavr)

Interventions for valvular diseaseTAVITools, devices and techniques

Share on Facebook Share on Twitter Share on Linkedin